Last deal

$60.M

Amount

Series G

Stage

25.03.2021

Date

1

all rounds

$60.M

Total amount

General

About Company
Synaptic Medical develops breakthrough medical devices for cardiovascular diseases.

Industry

Sector :

Subsector :

founded date

01.01.2005

Number of employees

Company Type

For Profit

Last funding type

Series G

IPO status

Private

Description

Founded in Minnesota in 2005, Synaptic Medical is a company that focuses on developing unique, cost-effective, and clinically advanced technologies for the treatment of cardiac arrhythmias and other cardiovascular diseases. The company offers breakthrough products for the treatment of cardiovascular diseases to enable physicians to optimize and expand treatment options. Synaptic Medical is committed to developing high-quality products that meet the needs of physicians and patients alike. With its expertise in cardiovascular electrophysiology devices, the company is well-positioned to make a significant impact in the field of cardiovascular medicine.
Contacts